This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Original Articles

Antidepressant Medication Treatment Failure Does Not Predict Lower Remission With ECT for Major Depressive Disorder: A Report From the Consortium for Research in Electroconvulsive Therapy

Keith G. Rasmussen, MD; Martina Mueller, PhD; Rebecca G. Knapp, PhD; Mustafa M. Husain, MD; Teresa A. Rummans, MD; Shirlene M. Sampson, MD; M. Kevin O'Connor, MD; Georgios Petrides, MD; Max Fink, MD, and Charles H. Kellner, MD

Published: November 15, 2007

Article Abstract

Objective: To test whether antidepressant medication treatment failure predicts differential remission with electroconvulsive therapy (ECT) in nonpsychotic unipolar depression.

Method: Depressed patients diagnosed with the Structured Clinical Interview for DSM-IV receiving ECT were assessed for medication use with the Antidepressant Treatment History Form (ATHF) (N = 345). Response to ECT was assessed with the 24-item Hamilton Rating Scale for Depression. Baseline medication treatment failure was analyzed as a possible predictor of remission status. Dates of study enrollment were from May 1997 to July 2004.

Results: Resistance to antidepressant medication as assessed by the ATHF, either taken as a whole or for any individual class of medication, was not predictive of acute remission status with ECT.

Conclusion: Treatment failure with antidepressant medication does not predict acute remission status with ECT for nonpsychotically depressed patients.

Volume: 68

Quick Links: Depression (MDD)

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women With Postpartum Depression

Zuranolone was associated with improvements in depressive and anxiety symptoms and was beneficial for insomnia and patient-perceived...

Read More...